Substance Use Disorders
Frances R. Levin, MD, Chief
The Division on Substance Use Disorders focuses on the causes and consequences of substance use disorders, with particular emphasis on the development and testing of novel approaches to the treatment of cocaine, opioid, cannabis and alcohol use disorders. A NIDA funded Medication Development Center, operating for more than 15 years, provides significant support of both clinical trials and laboratory behavioral pharmacology research. Additionally, researchers within the Division are examining the neural mechanisms that maintain substance use disorders and that underlie behavior change; the public health impact of substance use disorders; and the implementation and dissemination of treatments. In addition to its research mission, the Division faculty are dedicated to the training of the next generation of researchers and clinicians through a NIDA funded T32 fellowship in Substance Abuse Research; clinical training in Addiction Psychiatry; mentoring of junior faculty to become independent investigators; and education of residents and medical students.